OpenAlex
PricingAboutJobs
Log inGet started
Work

The Antiresorptive Effects of a Single Dose of Zoledronate Persist for Two Years: A Randomized, Placebo-Controlled Trial in Osteopenic Postmenopausal Women

HTML

Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Journal of Clinical Endocrinology & Metabolism
DOI: 10.1210/jc.2008-2241
Authors: Andrew Grey, Mark J. Bolland, Diana Wattie, Anne Horne, Greg Gamble, Ian R. Reid
Institution: University of Auckland
Language: English

Topic: Bone health and osteoporosis research
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Keywords: zoledronic acid, bisphosphonates, antiresorptive effect, duration of drug action, osteopenia, postmenopausal women, bone turnover markers, bone mineral density, secondary hyperparathyroidism, dosing interval, fracture risk
SDG: Good health and well-being

Open Access status: closed

Funder: Amgen
OpenAlex ID: W2081378515
FWCI: 12.06
Cites: 18
Cited by: 120
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security